# Medtronic Paceart Optima System - 20230630004

## Overview

If a healthcare delivery organization has enabled the optional Paceart Messaging Service in the Paceart Optima system, an unauthorized user could exploit this vulnerability to perform remote code execution and/or denial-of-service (DoS) attacks by sending specially crafted messages to the Paceart Optima system. Remote code execution could result in the deletion, theft, or modification of Paceart Optima systemâ€™s cardiac device data, or use of the Paceart Optima system for further network penetration. A DoS attack could cause the Paceart Optima system to slow or be unresponsive.

## What is the vulnerability?

[**CVE-2023-31222**](https://nvd.nist.gov/vuln/detail/CVE-2023-31222) - CVSS v3 Base Score: ***9.8***

## What is vulnerable?

The vulnerability exists in the following products:

- Medtronic's Paceart Optima versions 1.11

## What has been observed?

CISA added this vulnerabilty in their [ICS Medical Advisory](https://www.cisa.gov/news-events/ics-medical-advisories/icsma-23-180-01) catalog on June 29 2023. There is no evidence of exploitation affecting Western Australian Government networks at the time of publishing.

## Recommendation

The WA SOC recommends administrators apply mitigation controls as per vendor instructions to all affected devices or patching within expected timeframe of one month (refer [Patch Management](../guidelines/patch-management.md)):

- [Medtronic Application Security Update](https://global.medtronic.com/xg-en/product-security/security-bulletins/paceart-optima-system.html)
